Actuate Therapeutics, Inc. Shareholders' Equity
Actuate Therapeutics, Inc. (ACTU) had Shareholders' Equity of $989.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $989.15K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.92M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $10.94M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $989.15K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.78M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $7.92M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $10.94M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$2.65M 10-Q · filed 2026-08-14 |
| 2025-03-31 | -$5.09M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $104.19K 10-Q · filed 2026-08-14 |
| 2024-09-30 | $5.36M 10-Q · filed 2025-11-13 |
| 2024-06-30 | -$114.26M 10-Q · filed 2025-11-13 |
| 2024-03-31 | -$107.77M 10-Q · filed 2025-11-13 |
| 2023-12-31 | -$99.63M 10-K · filed 2026-03-26 |
| 2023-09-30 | -$92.14M 10-Q · filed 2024-11-13 |
| 2023-06-30 | -$85.95M 10-Q · filed 2024-11-13 |
| 2023-03-31 | -$80.50M 10-Q · filed 2024-11-13 |
| 2022-12-31 | -$75.31M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |